Posted from: Thursday, July 09, 2015 - 02:36 PM - Present

IMPORTANT INFORMATION: DRUG RECALL

Nexium Recalled

June 10, 2015, AstraZeneca voluntarily recalled Nexium (esomeprazole magnesium) delayed release 20mg capsules.  The Class II recall was prompted as a result of a retail pharmacist finding Seroquel (atypical antipsychotic quetiapine fumarate) in an unopened bottle of what should have been Nexium.

The recalled bottles are labeled Lot #FC0064 with an expiration date of May 2017.  This lot contains 34,524 bottles of Nexium being recalled.

For those members that have this product, it is suggested that they contact their pharmacy. 

For those members who use mail order, Benecard Central Fill has not dispensed any recalled lots of Nexium.

No adverse health reactions have been associated with this recall.  If you have any questions about this recall please contact your local retail pharmacist or speak to your doctor. 

Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:

Online: www.fda.gov/medwatch/report.htm

Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm.  Mail the form to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787

Fax: 1-800-FDA-0178

 

Last Updated Saturday, March 25, 2017 - 06:38 AM.